These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15703505)

  • 1. Predicting coronary risk in UK South Asians: an adjustment method for Framingham-based tools.
    Aarabi M; Jackson PR
    Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):46-51. PubMed ID: 15703505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data.
    Bhopal R; Fischbacher C; Vartiainen E; Unwin N; White M; Alberti G
    J Public Health (Oxf); 2005 Mar; 27(1):93-100. PubMed ID: 15749725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study.
    Cappuccio FP; Oakeshott P; Strazzullo P; Kerry SM
    BMJ; 2002 Nov; 325(7375):1271. PubMed ID: 12458243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk prediction tools for populations in Asia.
    ; Barzi F; Patel A; Gu D; Sritara P; Lam TH; Rodgers A; Woodward M
    J Epidemiol Community Health; 2007 Feb; 61(2):115-21. PubMed ID: 17234869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social networks and coronary heart disease risk factors in South Asians and Europeans in the UK.
    Pollard TM; Carlin LE; Bhopal R; Unwin N; White M; Fischbacher C
    Ethn Health; 2003 Aug; 8(3):263-75. PubMed ID: 14577999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study.
    Cooper JA; Miller GJ; Humphries SE
    Atherosclerosis; 2005 Jul; 181(1):93-100. PubMed ID: 15939059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxazosin versus bendrofluazide: a comparison of the metabolic effects in British South Asians with hypertension.
    Hobbs FR; Khan T; Collins B
    Br J Gen Pract; 2005 Jun; 55(515):437-43. PubMed ID: 15970067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting coronary risk in the general population--is it necessary to measure high-density lipoprotein cholesterol?
    Wilson S; Johnston A; Robson J; Poulter NR; Collier DJ; Feder GS; Caulfield MJ
    J Cardiovasc Risk; 2003 Apr; 10(2):137-41. PubMed ID: 12668911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region.
    Barzi F; Patel A; Woodward M; Lawes CM; Ohkubo T; Gu D; Lam TH; Ueshima H;
    Ann Epidemiol; 2005 May; 15(5):405-13. PubMed ID: 15840555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation.
    Ferrario M; Chiodini P; Chambless LE; Cesana G; Vanuzzo D; Panico S; Sega R; Pilotto L; Palmieri L; Giampaoli S;
    Int J Epidemiol; 2005 Apr; 34(2):413-21. PubMed ID: 15659467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in cortisol concentrations in South Asian and European men living in the United Kingdom.
    Reynolds RM; Fischbacher C; Bhopal R; Byrne CD; White M; Unwin N; Walker BR
    Clin Endocrinol (Oxf); 2006 May; 64(5):530-4. PubMed ID: 16649972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease risk assessment in older women: can we improve on Framingham? British Women's Heart and Health prospective cohort study.
    May M; Lawlor DA; Brindle P; Patel R; Ebrahim S
    Heart; 2006 Oct; 92(10):1396-401. PubMed ID: 16547204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus.
    Wannamethee SG; Shaper AG; Lennon L; Morris RW
    Arch Intern Med; 2005 Dec 12-26; 165(22):2644-50. PubMed ID: 16344423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study.
    Guzder RN; Gatling W; Mullee MA; Mehta RL; Byrne CD
    Diabet Med; 2005 May; 22(5):554-62. PubMed ID: 15842509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac risk scores in high-risk Hispanics and the predictive value of BNP.
    Macabasco-O'Connell A; Danwalder S; Sinha K
    J Clin Nurs; 2011 Nov; 20(21-22):3039-46. PubMed ID: 21592244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid screening to prevent coronary artery disease: a quantitative evaluation of evolving guidelines.
    Grover SA; Dorais M; Paradis G; Fodor JG; Frohlich JJ; McPherson R; Coupal L; Zowall H
    CMAJ; 2000 Nov; 163(10):1263-9. PubMed ID: 11107461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central obesity and cigarette smoking are key determinants of cardiovascular disease deaths in Australia: a public health perspective.
    Dhaliwal SS; Welborn TA
    Prev Med; 2009; 49(2-3):153-7. PubMed ID: 19660494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.